Soligenix SNGX
NASDAQ SNGX
$0.40 +0.02 (+5.50%)
At close: Aug 21, 2026 · 4:00 PM EDT

Soligenix (SNGX) Other Accumulated Expenses (2017 - 2026)

Soligenix's (SNGX) quarterly Other Accumulated Expenses came in at $390894.0 in Q1 2026, down 80.61% YoY from $2.0 million in Q1 2025, and up 43.66% on a QoQ basis from $272088.0 in Q4 2025.

Soligenix (SNGX) Other Accumulated Expenses (2017 - 2026) Analysis & Trends

Soligenix (SNGX) has 10 years of Other Accumulated Expenses data on file, last reported at $390894.0 in Q1 2026.

  • Quarterly Other Accumulated Expenses fell 80.61% year-over-year to $390894.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $390894.0 (down 80.61% YoY) and the FY2025 annual result came in at $272088.0, down 77.77% from the prior year.
  • Other Accumulated Expenses improved to $390894.0 in Q1 2026, from $272088.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $2.0 million in Q1 2025 to a low of $272088.0 in Q4 2025.
  • A 5-year average of $588208.9 and a median of $423629.0 in 2022 frame the typical range for Other Accumulated Expenses.
  • Annual changes were most pronounced in 2022 — Other Accumulated Expenses surged 2040.25% — and 2026, when it slumped 80.61%.
  • Tracing SNGX's Other Accumulated Expenses over 5 years: stood at $423629.0 in 2022, then grew by 0.14% to $424218.0 in 2023, then soared by 188.48% to $1.2 million in 2024, then sank by 77.77% to $272088.0 in 2025, then jumped by 43.66% to $390894.0 in 2026.
  • The last three Other Accumulated Expenses figures came in at $390894.0 (Q1 2026), $272088.0 (Q4 2025), and $454295.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Soligenix 6.45 Mn 6.45 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 574,428.00
Mar 31, 2026 390,894.00
Dec 31, 2025 272,088.00
Sep 30, 2025 454,295.00
Jun 30, 2025 1.05 Mn
Mar 31, 2025 2.02 Mn
Dec 31, 2024 1.22 Mn
Sep 30, 2024 412,206.00
Jun 30, 2024 345,198.00
Mar 31, 2024 531,710.00
Dec 31, 2023 424,218.00
Sep 30, 2023 304,636.00
Jun 30, 2023 376,962.00
Mar 31, 2023 437,113.00
Dec 31, 2022 423,629.00
Sep 30, 2022 322,230.00
Jun 30, 2022 417,884.00
Mar 31, 2022 594,575.00
Dec 31, 2021 330,766.00
Sep 30, 2021 16,952.00